Technology
Health
Biotechnology

Intra-Cellular Therapies

$11.85
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.16 (1.35%) Today
-$0.13 (-1.09%) As of 4:53 PM EDT after-hours

Why Robinhood?

You can buy or sell ITCI and other stocks, options, ETFs, and crypto commission-free!

About ITCI

Intra-Cellular Therapies Inc. Common Stock, also called Intra-Cellular Therapies, is a biopharmaceutical company, which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system, or CNS. Read More Its lead product candidate, ITI-007, is in clinical development as a first-in-class treatment for schizophrenia. The company also includes pre-clinical programs that are focused on advancing drug candidates for the treatment of cognitive dysfunction, in both schizophrenia and Alzheimer's disease, and for disease modification and the treatment of neurodegenerative disorders, including Alzheimer's disease. The company was founded by Paul Greengard and Sharon Mates on August 29, 2013 and is headquartered in New York, NY.

Employees
73
Headquarters
New York, New York
Founded
2013
Market Cap
651.65M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
2.22M
High Today
$12.02
Low Today
$11.31
Open Price
$11.92
Volume
872.08K
52 Week High
$23.62
52 Week Low
$10.09

Collections

Technology
Health
Biotechnology
2013 IPO
US
North America

ITCI News

BloombergJul 5

Intra-Cellular Shares May Double on Bipolar Depression Data

2,873

ITCI Earnings

-$0.91
-$0.79
-$0.67
-$0.55
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 1, Pre-Market

More ITCI News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.